Clinical trial
Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy
NCT00003825 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy
- Lead sponsor
- Radiation Therapy Oncology Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 1999
- Completion date
- Not reported
- Enrollment
- 174 (estimated)
- Sites
- 260
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea, radiation enteritis